Ticker Details
BridgeBio Pharma, Inc.
IPO Date:	June 24, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$15.93B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.00 | 3.20%
Avg Daily Range (30 D):	$1.58 | 1.89%
Avg Daily Range (90 D):	$1.48 | 1.97%

Institutional Daily Volume
Avg Daily Volume:	1.55M
Avg Daily Volume (30 D):	1.9M
Avg Daily Volume (90 D):	2.51M

Trade Size
Avg Trade Size (Sh.):	81
Avg Trade Size (Sh.) (30 D):	65
Avg Trade Size (Sh.) (90 D):	74

Institutional Trades
Total Institutional Trades:	9,357
Avg Institutional Trade:	$3.76M
Avg Institutional Trade (30 D):	$6.8M
Avg Institutional Trade (90 D):	$6.83M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$9.29M
Avg Closing Trade (30 D):	$29.94M
Avg Closing Trade (90 D):	$33.62M
Avg Closing Volume:	260.81K

News

Aug 14, 2026 @ 3:15 PM BridgeBio Stock Has Soared 29% in Just 3 Months. H... Source: Eric Volkman

Jul 7, 2026 @ 10:42 AM Transthyretin Amyloidosis Treatment Market Size to... Source: Sns Insider

Jul 2, 2026 @ 10:33 AM Wall Street Thinks This Biotech Stock Can Soar 45%... Source: James Halley

Jul 1, 2026 @ 11:30 AM BridgeBio Raises $1 Billion in Preferred Equity to... Source: Na

May 12, 2026 @ 12:30 PM Wall Street's Cardiac Bet: Where Diagnostics Meet ... Source: Usa News Group

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-3.56	$-.78	$-.84
Diluted EPS	$-3.56	$-.78	$-.84
Revenue	$713.07M	$243.68M	$194.52M
Gross Profit	$673.41M	$228.63M	$184.58M
Net Income / Loss	$-702.02M	$-155.89M	$-166.56M
Operating Income / Loss	$-497.8M	$-107.08M	$-105.96M
Cost of Revenue	$39.66M	$15.05M	$9.94M
Net Cash Flow	$-71.06M	$-201.98M	$309.88M
PE Ratio